Table 4. Anthropometric measures, body composition, and blood pressure in the two groups at baseline and follow-up: analysis restricted to participants who completed the study on assigned treatment condition.
Baseline | Week 26 | Change from baseline | Week 52 | Change from baseline | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||
FB (n=45) | MD (n=50) | FB (n=45) | MD (n=50) | FB (n=45) | MD (n=50) | P valuea | FB (n=45) | MD (n=50) | FB (n=45) | MD (n=50) | P valueb | |
Weight (kg) | 113.1c | 112.0 | 108.7 | 103.5 | −4.4* | −8.5* | 0.0001 | 110.4 | 106.7 | −2.7* | −5.3* | 0.0010 |
[113.1]d | [112.8] | [108.7] | [104.3] | [−4.4† ] | [−8.5† ] | [0.0094] | [110.5] | [107.5] | [−2.7† ] | [−5.3† ] | [0.0569] | |
(12.5)e | (17.4) | (13.7) | (17.0) | (7.4) | (8.3) | (13.3) | (17.1) | (6.7) | (7.2) | |||
BMI (kg/m2) | 41.5 | 40.4 | 39.9 | 37.4 | −1.6* | −3.0* | 0.0003 | 40.6 | 38.6 | −0.9* | −1.8* | 0.0024 |
[41.4] | [40.6] | [39.8] | [37.6] | [−1.6† ] | [−3.0† ] | [0.0111] | [40.4] | [38.7] | [−0.9† ] | [−1.8† ] | [0.0661] | |
(3.7) | (3.9) | (4.5) | (4.7) | (2.5) | (2.7) | (4.3) | (4.4) | (2.2) | (2.5) | |||
Waist (cm) | 111.8 | 107.0 | 107.4 | 100.7 | −4.4* | −6.3* | 0.0073 | 107.6 | 101.5 | −4.2* | −5.4* | 0.0114 |
[111.9] | [107.2] | [107.4] | [100.9] | [−4.4† ] | [−6.3† ] | [0.0470] | [107.7] | [101.7] | [−4.2† ] | [−5.4† ] | [0.0988] | |
(10.0) | (10.7) | (10.2) | (11.0) | (5.6) | (5.8) | (10.2) | (11.0) | (4.6) | (5.1) | |||
Fat mass (kg) | 54.6 | 53.5 | 50.4 | 46.2 | −4.2* | −7.3* | 0.0005 | 52.1 | 48.7 | −2.5* | −4.8* | 0.0021 |
[54.2] | [53.8] | [50.0] | [46.7] | [−4.2† ] | [−7.4† ] | [0.0173] | [51.6] | [49.0] | [−2.5† ] | [−4.8† ] | [0.0540] | |
(8.8) | (10.1) | (10.7) | (11.8) | (6.0) | (6.4) | (10.9) | (11.0) | (5.6) | (5.6) | |||
Fat-free mass (kg) | 58.3 | 58.5 | 58.1 | 57.3 | −0.2 | −1.3* | 0.0203 | 58.2 | 58.0 | −0.1 | −0.5 | 0.1319 |
[59.0] | [59.1] | [58.8] | [57.8] | [−0.2] | [−1.3† ] | [0.0771] | [58.9] | [58.5] | [−0.1] | [−0.5] | [0.4279] | |
(9.7) | (11.7) | (9.7) | (10.7) | (2.9) | (3.2) | (9.0) | (11.2) | (2.6) | (2.9) | |||
Fat-free mass/weight (%) | 51.6 | 52.3 | 53.7 | 55.7 | +2.1* | +3.4* | 0.0039 | 53.0 | 54.5 | +1.4* | +2.2* | 0.0187 |
[52.1] | [52.3] | [54.2] | [55.7] | [+2.1† ] | [+3.4† ] | [0.0618] | [53.5] | [54.5] | [+1.4† ] | [+2.2† ] | [0.1759] | |
(5.4) | (5.2) | (6.7) | (6.6) | (3.2) | (3.2) | (6.6) | (6.0) | (3.0) | (2.8) | |||
SBP (mm Hg) | 124.7 | 123.4 | 121.0 | 119.4 | −3.7 | −4.0* | 0.8032 | 124.4 | 123.2 | −0.2 | −0.2 | 0.9353 |
[124.7] | [123.6] | [121.0] | [119.6] | [−3.7] | [−4.0† ] | [0.7368] | [124.5] | [123.4] | [−0.2] | [−0.2] | [0.8623] | |
(13.5) | (13.7) | (11.1) | (13.5) | (11.8) | (13.4) | (12.6) | (14.7) | (9.3) | (10.4) | |||
DBP (mm Hg) | 74.0 | 73.9 | 73.2 | 72.0 | −0.8 | −1.9* | 0.4548 | 73.8 | 74.7 | −0.2 | +0.8 | 0.3545 |
[73.9] | [74.1] | [73.1] | [72.2] | [−0.8] | [−1.9† ] | [0.4181] | [73.7] | [74.9] | [−0.2] | [+0.8] | [0.3638] | |
(7.3) | (7.7) | (7.8) | (8.5) | (5.7) | (7.0) | (7.6) | (8.8) | (5.4) | (5.3) |
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FB, reduced-energy, food-based diet; MD, Medifast 5 & 1 Plan; SBP, systolic blood pressure.
P <0.05 for within-group difference in change in measure between baseline and week 26 or baseline and week 52 from mixed model analysis of covariance with adjustment for race.
P <0.05 for within-group difference in change in measure between baseline and week 26 or baseline and week 52 from mixed model analysis.
P value for between-group difference in change in measure at week 26 from mixed model analysis of covariance with adjustment for the relevant baseline measure and ethnicity [p-value in parentheses does not adjust for ethnicity as a covariate].
P value for between-group difference in change in measure at week 52 from mixed model analysis of covariance with adjustment for the relevant baseline measure and ethnicity [p-value in parentheses does not adjust for ethnicity as a covariate].
Mean (adjusted for race).
Mean (unadjusted).
Standard deviation.